Abstract
Purpose
Acromegaly in infancy is extremely rare. We describe a 32 year old woman who presented at 6 months of age with isolated macrocephaly, followed by accelerated linear growth. At 21 months of age, her head circumference was 55 cm (+5.5 SD), height was 97.6 cm (+4.4 SD) and weight was 20.6 kg (+6.2 SD). She had markedly elevated levels of growth hormone (GH) (135 ng/ml), IGF-1 (1540 ng/ml) and prolactin (370 ng/ml). A pituitary macroadenoma was surgically resected. Immunohistochemical staining was positive for GH. Post-operatively, she developed ACTH and TSH deficiency and diabetes insipidus.
Methods
Long term clinical follow-up and genetic testing with chromosomal microarray analysis.
Results
Despite GH deficiency, she grew well until 7 ½ years old, with subsequent decline in growth velocity, and received GH therapy for 5 years. Puberty was initiated with estrogen therapy. As an adult, she has no stigmata of acromegaly, with a height of 164.5 cm and non-acromegalic features. IGF-1 has remained in the low normal range. Prolactin has been mildly elevated. Serial MRIs have shown no evidence of tumor recurrence. She receives replacement therapy with hydrocortisone, levothyroxine and DDAVP. Chromosomal microarray analysis revealed that she has X-linked acrogigantism (X-LAG) due to a de novo duplication of Xq26.3 (516 kb). She recently became pregnant following ovarian stimulation and chorionic villus sampling revealed that she is carrying a male with the same duplication.
Conclusion
This report provides detailed long term clinical follow-up of a patient with X-LAG syndrome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rostomyan L, Daly AF, Petrossians P, Nachev E, Lila AR, Lecoq A-L et al (2015) Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr Relat Cancer 22:745–757
Blumberg DL, Sklar CA, David R, Rothenberg S, Bell J (1989) Acromegaly in an Infant. Pediatrics 83:998–1002
Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO et al (2014) Gigantism and Acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med 371:2363–2374
Naves LA, Daly AF, Dias LA, Yuan B, Zakir JCO, Barra GB, et al. (2015) Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome. Endocrine 2015 Nov (Epub, ahead of print)
Beckers A, Lodish MB, Trivellin G, Rostomyan L, Lee M, Faucz FR et al (2015) X-linked acrogigantism syndrome: clinical profile and therapeutic responses. Endocr Relat Cancer 22:353–367
Rostomyan L, Daly AF, Beckers A (2015) Pituitary gigantism: causes and clinical characteristics. Ann Endocrinol (Paris) 76:643–649
Daly AF, Lysy PA, Desfilles C, Rostomyan L, Mohamed A, Caberg JH et al (2016) GHRH excess and blockade in X-LAG syndrome. Endocr Relat Cancer 23(3):161–170
Daly AF, Yuan B, Fina F, Caberg JH, Trivellin G, Rostomyan L et al (2016) Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects. Endocr Relat Cancer 23(4):221–233
Acknowledgments
NIH/NIDDK T32DK065522 (RJG and SEO).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Gordon, R.J., Bell, J., Chung, W.K. et al. Childhood acromegaly due to X-linked acrogigantism: long term follow-up. Pituitary 19, 560–564 (2016). https://doi.org/10.1007/s11102-016-0743-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-016-0743-0